What is the plasma half-life of Oxymetholone in Balkan Pharmaceuticals Anapolon tablets?

The plasma elimination half-life of Oxymetholone is approximately 8–9 hours, as characterised in pharmacological literature using HPLC-based plasma assay methods. This places it in the mid-range of oral anabolic androgens — longer than Methandienone (3–5 hours) but broadly comparable to oral Stanozolol. The half-life directly determines that twice-daily dosing is sufficient to maintain meaningful plasma trough levels without excessive accumulation.

How quickly does Oxymetholone reach peak plasma concentration after taking a tablet?

Peak plasma concentration (Tmax) is typically achieved within 1–2 hours of oral ingestion under fasted or light-meal conditions. The 17α-alkyl modification that protects Oxymetholone from first-pass hepatic clearance ensures that gastrointestinal absorption translates into measurable systemic exposure within this window. Users timing intra-workout administration should account for this 1–2 hour absorption phase when scheduling doses relative to training sessions.

How does the half-life of Oxymetholone compare to other oral anabolic androgens in terms of dosing frequency?

Oxymetholone's 8–9 hour half-life positions it favourably compared to Methandienone (3–5 hours), which often demands three daily administrations to avoid plasma troughs. Unlike faster-clearing orals, Oxymetholone's longer half-life allows a clinically adequate twice-daily schedule — typically morning and evening — keeping plasma levels more stable across a 24-hour period without requiring mid-day dosing.

How does the 50 mg per tablet concentration of Balkan Anapolon affect dose flexibility compared to lower-strength Oxymetholone products?

At 50 mg per tablet, Balkan Anapolon carries the highest per-unit concentration available in standard Oxymetholone tablet formulations. This allows experienced users to reach a 100 mg daily dose with just two tablets while also enabling straightforward halving for 25 mg sub-doses when tablets are scored. Lower-strength products require more tablets per dose to reach the same exposure, increasing pill burden and compounding any tablet-to-tablet potency variance.

Can Balkan Anapolon 50mg tablets be split, and does splitting affect potency accuracy?

Balkan Anapolon tablets are scored for splitting, permitting 25 mg sub-dose administration. Because each tablet is HPLC-verified at the full 50 mg specification before release, a clean split yields two portions with a predictable potency starting point — unlike unverified tablets where splitting amplifies any existing content variance. Splitting is particularly relevant for users titrating dose during the introductory phase of a cycle based on individual tolerance. (2) angle_used

HPLC Verified

Balkan Pharmaceuticals

Anapolon 50mg/tab 60 Tabletten by Balkan Pharmaceuticals

Name: Anapolon 50mg/tab 60 Tablets by Balkan Pharmaceuticals
Brand: Balkan Pharmaceuticals
SKU: ORA-OXYM-BAL-002
Price: 48.00 EUR
Availability: InStock

Anapolon by Balkan Pharmaceuticals is an oral anabolic tablet delivering 50 mg of Oxymetholone per dose, clinically characterised by a plasma half-life of approximately 8–9 hours that governs its twice-daily administration schedule. The pharmacokinetic profile allows predictable plasma-level maintenance without the accumulation spikes associated with longer-half-life oral androgens, making timed dosing a core performance variable. Batch-release integrity is enforced through post-compression HPLC quantification and LAL endotoxin screening — each of the 60 tablets verified against declared potency before dispatch.

€48.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

HPLC-confirmed 50 mg potency per tablet ensures every dose matches the pharmacokinetic model you plan around.
Eight-to-nine hour plasma half-life supports a straightforward twice-daily administration schedule.
60-tablet pack provides a complete 30-day supply at standard twice-daily dosing without mid-cycle restocking.
Scored tablet format enables precise 25 mg sub-dosing for introductory phase titration.
LAL endotoxin testing applied at batch release adds a safety verification layer beyond standard API quantification.
Single active ingredient formulation — no secondary compounds that could alter the expected Oxymetholone pharmacokinetic curve.
Produced within Balkan Pharmaceuticals' GMP-certified Chișinău facility, with documented batch-release records available through authorised distributors.

note: Dosing intervals are structured around the 8–9 hour plasma half-life of Oxymetholone to maintain consistent plasma trough levels.

Phase	dosage	Note
Introductory (Weeks 1–2)	50 mg/day (1 tablet × 2 half-doses or 1 full tablet)	Establish individual GI and hepatic tolerance; administer doses ~8–9 hours apart aligned with half-life clearance.
Main Cycle (Weeks 3–6)	100 mg/day (1 tablet every ~12 hours)	Twice-daily schedule maintains plasma trough above baseline; avoid extending beyond 6 weeks at this level due to cumulative 17α-alkylation hepatic load.
Taper / Transition (Week 7, if used)	50 mg/day (return to introductory dose)	Gradual reduction limits abrupt plasma-level drop ahead of PCT initiation; discontinue approximately 24–36 hours before beginning PCT, accounting for residual half-life clearance.

Key takeaways

Plan twice-daily dosing around Oxymetholone's confirmed 8–9 hour plasma half-life.
Expect peak plasma levels within 1–2 hours of each 50 mg tablet dose.
Choose HPLC-Verified tablets to anchor pharmacokinetic assumptions in real potency data.
Leverage the 50 mg strength to reach target doses with minimal daily tablet count.
Monitor hepatic markers consistently given 17α-alkylation and multi-week oral exposure.

Oxymetholone Pharmacokinetics: What the Half-Life Data Actually Means for Dosing

Anapolon by Balkan Pharmaceuticals is an oral anabolic agent whose clinical behaviour is fundamentally governed by the pharmacokinetic signature of Oxymetholone — a 17α-alkylated dihydrotestosterone derivative with a reported plasma elimination half-life of 8–9 hours, measured by HPLC-based plasma assay methods in pharmacological literature. That half-life is the single most operationally relevant number for any user of this compound: it determines how quickly plasma concentrations decline between doses, how rapidly peak levels are achieved post-ingestion, and how often administration must occur to maintain a therapeutically meaningful trough. Compared to shorter-half-life oral androgens such as oral Stanozolol (approximately 9 hours, similar) or Methandienone (3–5 hours), Oxymetholone occupies a mid-range oral half-life window that permits twice-daily dosing without the three-times-daily scheduling sometimes required by faster-clearing molecules.

Absorption, Tmax, and Plasma-Level Architecture

Oral bioavailability of Oxymetholone is preserved by its 17α-alkyl modification, which resists first-pass hepatic degradation sufficiently to yield meaningful systemic exposure after gastrointestinal absorption. Peak plasma concentration (Tmax) is typically reached within 1–2 hours of ingestion under fasted conditions, according to pharmacokinetic characterisation data referenced in clinical endocrinology research. Each 50 mg tablet from Balkan Pharmaceuticals delivers a single, HPLC-confirmed dose unit, meaning the plasma-level curve is seeded from a precisely quantified starting point — not an estimated one. Oxymetholone undergoes hepatic metabolism to inactive glucuronide and sulphate conjugates, which are renally excreted; urinary detection windows extend well beyond the plasma half-life due to this metabolite persistence.

Why Tablet Potency Verification Matters for Pharmacokinetic Predictability

Pharmacokinetic modelling is only as reliable as the dose accuracy of the product consumed. Balkan Pharmaceuticals subjects each Anapolon batch to post-compression HPLC assay against the declared 50 mg/tablet specification, with LAL (Limulus Amebocyte Lysate) endotoxin testing applied as an additional release criterion. A tablet delivering, for example, 42 mg instead of 50 mg would flatten the expected plasma-concentration peak by roughly 16 % — a clinically meaningful deviation in compounds where dose-response relationships are steep. The HPLC-Verified badge on this product signals that the pharmacokinetic assumptions underpinning any rational dosing protocol are grounded in confirmed tablet potency, not label claims alone. Each pack of 60 tablets represents a 30-day supply at a standard twice-daily protocol, providing logistical continuity across a full cycle phase.

Usage

Calculate your total daily dose in multiples of 50 mg (the verified tablet strength) before beginning — do not estimate; use the confirmed HPLC-assayed unit as your baseline.
Divide the daily dose into two equal administrations spaced approximately 10–12 hours apart, corresponding to the 8–9 hour half-life to prevent excessive plasma troughs between doses.
Take each tablet with a moderate meal or immediately after eating to reduce gastrointestinal irritation associated with high-dose oral androgens; avoid fasted high-intensity dosing in the introductory weeks.
If splitting tablets for a 25 mg sub-dose, use a clean pill cutter along the score line — do not crush, as this disrupts controlled disintegration and alters the expected absorption timeline.
Log each dose with a timestamp to verify adherence to the twice-daily interval; plasma-level modelling is only meaningful when actual administration times match the theoretical half-life schedule.
Schedule baseline liver enzyme tests (ALT, AST) before the first dose and repeat every three weeks during the cycle; the 8–9 hour half-life means hepatic exposure is continuous across a multi-week oral course, and early biomarker elevation warrants immediate dose review.

Warnings

contraindications: Anapolon is contraindicated in individuals with existing hepatic impairment, prostatic carcinoma, breast carcinoma in males, hypercalcaemia, nephrotic syndrome, or documented hypersensitivity to Oxymetholone or any excipient. Not approved for use in females of childbearing potential or in individuals under 18 years of age.

side_effects: Oxymetholone carries a documented hepatotoxicity profile consistent with 17α-alkylated oral androgens, including elevated serum transaminases (ALT/AST), cholestatic jaundice, and, in rare prolonged cases, peliosis hepatis. Cardiovascular effects include LDL elevation and HDL suppression. Oedema due to sodium and water retention is common at doses of 50–100 mg/day. Androgenic effects — including accelerated scalp recession in genetically predisposed individuals and acne — may occur despite the DHT-derived backbone. Endogenous testosterone suppression is profound and dose-dependent.

monitoring: Liver function panels (ALT, AST, bilirubin, ALP) should be obtained at baseline, at three-week intervals during the cycle, and four weeks post-cycle. Lipid profile (LDL, HDL, total cholesterol) and haematocrit should be monitored given Oxymetholone's known erythropoietic activity — haemoglobin elevation above 17.5 g/dL warrants cycle interruption. Blood pressure should be recorded weekly given sodium-retention-related volume expansion.

pct: Post-cycle therapy should commence approximately 24–48 hours after the final Oxymetholone tablet, timed to coincide with the expected plasma clearance based on the 8–9 hour half-life (approximately 4–5 half-lives = 36–45 hours to near-complete clearance). A SERM-based PCT protocol using Tamoxifen (40 mg/day for 2 weeks, then 20 mg/day for 2 weeks) or Clomiphene Citrate is standard. SHBG normalisation and endogenous LH/FSH recovery should be confirmed before considering any further cycle.

Frequently asked questions

What is the plasma half-life of Oxymetholone in Balkan Pharmaceuticals Anapolon tablets?: The plasma elimination half-life of Oxymetholone is approximately 8–9 hours, as characterised in pharmacological literature using HPLC-based plasma assay methods. This places it in the mid-range of oral anabolic androgens — longer than Methandienone (3–5 hours) but broadly comparable to oral Stanozolol. The half-life directly determines that twice-daily dosing is sufficient to maintain meaningful plasma trough levels without excessive accumulation.
How quickly does Oxymetholone reach peak plasma concentration after taking a tablet?: Peak plasma concentration (Tmax) is typically achieved within 1–2 hours of oral ingestion under fasted or light-meal conditions. The 17α-alkyl modification that protects Oxymetholone from first-pass hepatic clearance ensures that gastrointestinal absorption translates into measurable systemic exposure within this window. Users timing intra-workout administration should account for this 1–2 hour absorption phase when scheduling doses relative to training sessions.
How does the half-life of Oxymetholone compare to other oral anabolic androgens in terms of dosing frequency?: Oxymetholone's 8–9 hour half-life positions it favourably compared to Methandienone (3–5 hours), which often demands three daily administrations to avoid plasma troughs. Unlike faster-clearing orals, Oxymetholone's longer half-life allows a clinically adequate twice-daily schedule — typically morning and evening — keeping plasma levels more stable across a 24-hour period without requiring mid-day dosing.
How does the 50 mg per tablet concentration of Balkan Anapolon affect dose flexibility compared to lower-strength Oxymetholone products?: At 50 mg per tablet, Balkan Anapolon carries the highest per-unit concentration available in standard Oxymetholone tablet formulations. This allows experienced users to reach a 100 mg daily dose with just two tablets while also enabling straightforward halving for 25 mg sub-doses when tablets are scored. Lower-strength products require more tablets per dose to reach the same exposure, increasing pill burden and compounding any tablet-to-tablet potency variance.
Can Balkan Anapolon 50mg tablets be split, and does splitting affect potency accuracy?: Balkan Anapolon tablets are scored for splitting, permitting 25 mg sub-dose administration. Because each tablet is HPLC-verified at the full 50 mg specification before release, a clean split yields two portions with a predictable potency starting point — unlike unverified tablets where splitting amplifies any existing content variance. Splitting is particularly relevant for users titrating dose during the introductory phase of a cycle based on individual tolerance. (2) angle_used

Manufacturer

The release sequence applied to Anapolon within Balkan Pharmaceuticals' Chișinău tablet facility is built around a principle that quality data must precede market release — not accompany it as paperwork. Raw Oxymetholone API enters the production environment only after identity and purity characterisation against pharmacopoeial reference standards; tablets then progress through compression under GMP-certified cleanroom conditions before each batch is subjected to post-compression HPLC quantification against the 50 mg declared specification. A separate LAL (Limulus Amebocyte Lysate) endotoxin assay serves as an additional biological-safety release criterion applied at the batch level — a control parameter that goes beyond the minimum required for oral solid-dose forms and reflects the company's analytical infrastructure investment since its 2006 Chișinău founding. Only batches clearing both the HPLC potency gate and the LAL endotoxin threshold receive the batch-release certificate that authorises dispatch through Balkan's authorised wholesale network.

Product details

Brand	Balkan Pharmaceuticals
Active ingredient	oxymetholone
Also known as	Anadrol, Anapolon, Oxymetholone, Balkan Pharmaceuticals Anadrol
Strength	50 mg
Form	Tabletten
Pack size	60 pieces
Item number	ORA-OXYM-BAL-002

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Anapolon 50mg/tab 20 Tablets by Abdi Ibrahim

Lab Tested

Anapolon 50mg/tab 20 Tabletten by Abdi Ibrahim

Anapolon (Oxymetholone) by Abdi Ibrahim is a 17α-alkylated dihydrotestosterone-derived oral anabolic steroid, dosed at 50 mg per tablet across 20 tablets, whose primary pharmacological identity is defined by its high-affinity interaction with androgen receptors combined with a marked capacity to stimulate erythropoietin production. As a DHT-lineage compound, Oxymetholone cannot be aromatised directly yet drives powerful anabolic signalling through androgen receptor activation and progesterone receptor cross-reactivity. Quality is enforced at every production stage: HPLC purity verification, LAL endotoxin testing, and GMP-certified manufacturing conditions underpin every blister pack released by Abdi Ibrahim.

€20.00

Pro-Anadrol 50mg/tab 50 Tablets by Beligas Pharmaceuticals

Pharma Grade

Pro-Anadrol 50mg/tab 50 Tabletten by Beligas Pharmaceuticals

Pro-Anadrol delivers Oxymetholone at 50 mg per tablet across a 50-tablet pack — an oral androgen whose systemic bioavailability is shaped entirely by first-pass hepatic metabolism, distinguishing its absorption profile sharply from any injectable androgenic compound. Because the molecule must survive gastrointestinal transit and initial liver processing before entering systemic circulation, oral Oxymetholone achieves estimated bioavailability in the 56–70 % range, a figure that injectable routes bypass entirely by delivering the active substance directly into the bloodstream. Batch-level potency is confirmed at Beligas Pharmaceuticals through HPLC quantification against certified pharmacopoeial reference standards, with LAL endotoxin screening applied to raw excipient inputs before tableting proceeds.

€60.00

OxyTrex 25mg/tab 100 Tablets by Concentrex Labs

Purity Tested

OxyTrex 25mg/tab 100 Tabletten by Concentrex Labs

OxyTrex by Concentrex Labs delivers Oxymetholone at 25 mg per tablet across 100 tablets, formulated specifically for athletes studying how this potent oral androgen interacts with insulin sensitivity and glucose partitioning during hypertrophic loading phases. Oxymetholone's documented capacity to alter nutrient uptake dynamics — shifting glucose disposal toward skeletal muscle — makes it a subject of sustained interest in metabolic-context bodybuilding literature. Purity Tested at the finished-tablet stage via HPLC quantification; each released lot carries a batch record confirming active-content compliance against a certified reference standard.

€60.00

Oxymetholon 50mg/tab 100 Tablets by Dragon-Pharma

Batch Tested

Oxymetholon 50mg/tab 100 Tabletten by Dragon-Pharma

Dragon-Pharma Oxymetholone 50mg/tab is a pharmaceutical-grade oral anabolic steroid — 100 tablets per container — distinguished by its position as the highest per-tablet concentration in its product class, making receptor tolerance management and deliberate desensitization breaks the central consideration for responsible cycling. At 50 mg per tablet, precise dose adjustment across a cycle is straightforward, giving athletes the flexibility to step down before receptor downregulation diminishes returns. Quality assurance is built into every lot: each batch cleared HPLC quantification and LAL endotoxin screening under GMP-certified conditions before release.

€70.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00